Enhatch Partners with 3D Systems to Scale Personalized Medical Device Delivery

ROCK HILL, South Carolina, HOBOKEN, New Jersey, and TULSA, Oklahoma, March 23, 2022 – Today, 3D Systems (NYSE:DDD), the leading additive manufacturing solutions partner, and Enhatch Inc, the Hoboken, New Jersey and Tulsa, Oklahoma-based developer of the Intelligent Surgery Ecosystem, announced they have entered a partnership. The technologies which drive Intelligent Surgery streamline and scale the design and delivery of patient-specific medical devices by automating the process. Incorporating these capabilities into 3D Systems’ proven workflow for patient-specific solutions—which includes advanced software, expert treatment planning services, custom implants and instrumentation design, and industry-leading production processes—will help more efficiently meet the growing demand for personalized medical devices.

Enhatch’s Intelligent Surgery Ecosystem – powered by AI - streamlines and scales the design and delivery of patient-specific medical devices by automating the process. (Image courtesy of Enhatch)

‍

3D Systems partners with medical device manufacturers to offer its VSP® surgical planning solutions to support craniomaxillofacial and orthopedic medical specialties to help reduce procedure time and improve surgical outcomes. Likewise, Enhatch develops software applications powered by artificial intelligence to streamline every element of the patient-specific digital workflow. Enhatch is the first company to market an ecosystem of surgical technologies driven by artificial intelligence, which helps evaluate and mitigate potential risks in the surgical planning process. Combining the application and technology expertise of both companies creates an optimized, automated, and scalable medical device workflow.

“Our partnership with Enhatch will enable us to deliver the healthcare industry’s most comprehensive approach to additive manufacturing,” said Menno Ellis, executive vice president, healthcare solutions, 3D Systems. “Integrating these technologies and capabilities into 3D Systems’ surgical planning solutions will make processes more efficient, trackable, and cost-effective. This is another step in our ongoing commitment to innovation that helps our customers remain at the forefront of medical device development and healthcare delivery.”

As a pioneer in personalized healthcare solutions, 3D Systems has worked with surgeons over the last decade to plan more than 140,000 patient-specific cases, and manufacture more than two million implants and instruments for 100+ CE-marked and FDA-cleared devices from its world-class, FDA registered, ISO 13485-certified facilities in Littleton, Colorado, and Leuven, Belgium. The company will feature its solutions, including its partnership with Enhatch, in its booth (#1014) at the AAOS 2022 Annual Meeting, March 23-25 at McCormick Place in Chicago, Illinois. For more information, please visit the company’s website.